Fresenius Medical Care AG & Co. KGaA
FMS Healthcare Medical Care Facilities
Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024. In the quarter to June 2026, revenue grew 3.89%, EPS grew 6.82%, free cash flow grew 1.57% and total debt rose 5.57%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
Follow FMS
Fresenius Medical Care AG & Co. KGaA (FMS) EV/Sales
As of 16 October 2026, Fresenius Medical Care AG & Co. KGaA (FMS) trades at a EV/Sales of 0.8×. Over the past ten years it has ranged from 0.7× (October 2022) to 2.2× (November 2015); the current reading is higher than 4% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.9× | 1.81% |
| FY2024 | 0.9× | (4.07%) |
| FY2023 | 0.9× | 9.24% |
| FY2022 | 0.8× | (36.37%) |
| FY2021 | 1.3× | (16.75%) |
| FY2020 | 1.6× | (1.35%) |
| FY2019 | 1.6× | 19.24% |
| FY2018 | 1.3× | (31.52%) |
| FY2017 | 2.0× | 4.14% |
| FY2016 | 1.9× | (6.15%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.8× | (1.39%) |
| Mar 2026 | 0.9× | (3.54%) |
| Dec 2025 | 0.9× | (8.94%) |
| Sep 2025 | 1.0× | (7.92%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA | 0.8× |
| UHS Universal Health Services, Inc. compare | 0.9× |
| PACS PACS Group, Inc. compare | 1.4× |
| THC Tenet Healthcare Corporation compare | 1.5× |
| DVA DaVita Inc. compare | 1.6× |
| ENSG The Ensign Group, Inc. compare | 1.8× |
| EHC Encompass Health Corporation compare | 2.4× |
| CHE Chemed Corporation compare | 2.6× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.7× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)